Natera, Inc. (NTRA) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Natera, Inc. (NTRA) Bundle
Optimize your time and improve precision with our [NTRA] DCF Calculator! Utilizing real Natera, Inc. data and customizable assumptions, this tool empowers you to forecast, analyze, and evaluate Natera, Inc. like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 302.3 | 391.0 | 625.5 | 820.2 | 1,082.6 | 1,495.1 | 2,064.8 | 2,851.6 | 3,938.1 | 5,438.7 |
Revenue Growth, % | 0 | 29.33 | 59.97 | 31.13 | 31.99 | 38.1 | 38.1 | 38.1 | 38.1 | 38.1 |
EBITDA | -104.4 | -206.0 | -451.5 | -520.8 | -383.3 | -772.3 | -1,066.6 | -1,473.1 | -2,034.4 | -2,809.6 |
EBITDA, % | -34.53 | -52.67 | -72.19 | -63.5 | -35.4 | -51.66 | -51.66 | -51.66 | -51.66 | -51.66 |
Depreciation | 7.7 | 8.6 | 11.3 | 30.5 | 38.6 | 41.4 | 57.2 | 78.9 | 109.0 | 150.6 |
Depreciation, % | 2.56 | 2.2 | 1.8 | 3.72 | 3.57 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 |
EBIT | -112.1 | -214.6 | -462.8 | -551.3 | -421.9 | -813.7 | -1,123.8 | -1,552.0 | -2,143.4 | -2,960.2 |
EBIT, % | -37.09 | -54.87 | -73.99 | -67.21 | -38.97 | -54.43 | -54.43 | -54.43 | -54.43 | -54.43 |
Total Cash | 441.0 | 737.3 | 914.3 | 898.3 | 879.0 | 1,438.8 | 1,987.1 | 2,744.3 | 3,790.0 | 5,234.2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 53.4 | 78.6 | 122.1 | 244.4 | 278.3 | 337.2 | 465.6 | 643.1 | 888.1 | 1,226.5 |
Account Receivables, % | 17.65 | 20.09 | 19.52 | 29.79 | 25.71 | 22.55 | 22.55 | 22.55 | 22.55 | 22.55 |
Inventories | 12.4 | 20.0 | 26.9 | 35.4 | 40.8 | 64.6 | 89.2 | 123.2 | 170.2 | 235.0 |
Inventories, % | 4.1 | 5.12 | 4.3 | 4.32 | 3.77 | 4.32 | 4.32 | 4.32 | 4.32 | 4.32 |
Accounts Payable | 8.6 | 8.1 | 27.2 | 31.1 | 15.0 | 43.2 | 59.7 | 82.4 | 113.8 | 157.2 |
Accounts Payable, % | 2.85 | 2.07 | 4.35 | 3.8 | 1.39 | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 |
Capital Expenditure | -5.0 | -19.6 | -41.0 | -47.7 | -39.2 | -67.7 | -93.5 | -129.2 | -178.4 | -246.4 |
Capital Expenditure, % | -1.64 | -5.01 | -6.56 | -5.82 | -3.62 | -4.53 | -4.53 | -4.53 | -4.53 | -4.53 |
Tax Rate, % | -0.06236623 | -0.06236623 | -0.06236623 | -0.06236623 | -0.06236623 | -0.06236623 | -0.06236623 | -0.06236623 | -0.06236623 | -0.06236623 |
EBITAT | -114.0 | -214.7 | -463.4 | -552.3 | -422.2 | -813.7 | -1,123.8 | -1,552.0 | -2,143.4 | -2,960.2 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -168.3 | -259.0 | -524.5 | -696.3 | -478.1 | -894.6 | -1,296.8 | -1,791.0 | -2,473.4 | -3,415.9 |
WACC, % | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 |
PV UFCF | ||||||||||
SUM PV UFCF | -6,720.3 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -3,484 | |||||||||
Terminal Value | -36,684 | |||||||||
Present Terminal Value | -21,289 | |||||||||
Enterprise Value | -28,009 | |||||||||
Net Debt | -200 | |||||||||
Equity Value | -27,809 | |||||||||
Diluted Shares Outstanding, MM | 115 | |||||||||
Equity Value Per Share | -241.82 |
What You Will Get
- Real NTRA Financial Data: Pre-filled with Natera’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Natera’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Forecast Inputs: Adjust essential factors such as revenue growth, gross margin %, and R&D expenditures.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional financial metrics.
- High-Precision Accuracy: Leverages Natera’s actual financial data for dependable valuation results.
- Effortless Scenario Analysis: Evaluate various assumptions and assess results with ease.
- Efficiency Booster: Remove the complexity of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file for Natera, Inc. (NTRA).
- Step 2: Review Natera's pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment decisions.
Why Choose This Calculator?
- Accuracy: Utilizes real Natera financials to ensure data precision.
- Flexibility: Built for users to easily test and modify their inputs.
- Time-Saving: Eliminate the need to create a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected at the CFO level.
- User-Friendly: Intuitive interface suitable for users without extensive financial modeling knowledge.
Who Should Use Natera, Inc. (NTRA)?
- Healthcare Professionals: Understand genetic testing methodologies and their applications in patient care.
- Researchers: Utilize Natera's data for studies related to genomics and precision medicine.
- Investors: Evaluate market potential and performance metrics of Natera, Inc. (NTRA) for informed investment decisions.
- Biotech Analysts: Enhance your analysis with tailored models specific to the genetic testing industry.
- Patients and Families: Learn about the benefits of genetic testing and how it can impact health outcomes.
What the Template Contains
- Preloaded NTRA Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.